130 related articles for article (PubMed ID: 17174106)
1. Low-energy-loss electron microscopy of doxorubicin in human breast cancer MCF-7 cells: localization by color.
Mhawi AA; Fernandes AB; Ottensmeyer FP
J Struct Biol; 2007 Apr; 158(1):80-92. PubMed ID: 17174106
[TBL] [Abstract][Full Text] [Related]
2. Interaction of doxorubicin with the subcellular structures of the sensitive and Bcl-xL-overexpressing MCF-7 cell line: confocal and low-energy-loss transmission electron microscopy.
Mhawi AA
Micron; 2009 Oct; 40(7):702-12. PubMed ID: 19502069
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy.
Wartenberg M; Acker H
Anticancer Res; 1996; 16(2):573-9. PubMed ID: 8687100
[TBL] [Abstract][Full Text] [Related]
4. Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.
Chen Y; Walsh RJ; Arriaga EA
Anal Chem; 2005 Apr; 77(8):2281-7. PubMed ID: 15828758
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
7. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
8. Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line.
Rusetskaya NV; Khariton N; Yurchenko OV; Chekhun VF
Exp Oncol; 2011 Jun; 33(2):78-82. PubMed ID: 21716203
[TBL] [Abstract][Full Text] [Related]
9. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage.
Lee Y; Park SY; Mok H; Park TG
Bioconjug Chem; 2008 Feb; 19(2):525-31. PubMed ID: 18163537
[TBL] [Abstract][Full Text] [Related]
12. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
[TBL] [Abstract][Full Text] [Related]
13. Nuclear uptake of ultrasmall gold-doxorubicin conjugates imaged by fluorescence lifetime imaging microscopy (FLIM) and electron microscopy.
Zhang X; Shastry S; Bradforth SE; Nadeau JL
Nanoscale; 2015 Jan; 7(1):240-51. PubMed ID: 25407725
[TBL] [Abstract][Full Text] [Related]
14. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
15. Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells.
Na K; Lee ES; Bae YH
Bioconjug Chem; 2007; 18(5):1568-74. PubMed ID: 17688320
[TBL] [Abstract][Full Text] [Related]
16. Light, fluorescent, and electron microscopic analysis of cultured breast tumor cells (T-47D) treated with 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride.
Tseng MT; Safa AR
Cancer Res; 1983 Dec; 43(12 Pt 1):5910-4. PubMed ID: 6640539
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells.
Dai X; Yue Z; Eccleston ME; Swartling J; Slater NK; Kaminski CF
Nanomedicine; 2008 Mar; 4(1):49-56. PubMed ID: 18249155
[TBL] [Abstract][Full Text] [Related]
18. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells.
Tao X; Chen H; Sun XJ; Chen JF; Roa WH
Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293
[TBL] [Abstract][Full Text] [Related]
19. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
20. Characterization of doxorubicin binding site and drug induced alteration in the functionally important structural state of oxyhemoglobin.
Khan SN; Islam B; Yennamalli R; Zia Q; Subbarao N; Khan AU
J Pharm Biomed Anal; 2008 Dec; 48(4):1096-104. PubMed ID: 18842373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
